About Careers MedBlog Contact us

New Cloud-Based Diabetic Retinopathy Screening Solution - EyeArt - Receives CE Marking

by Vishnuprasad on April 24, 2015 at 8:44 PM
Font : A-A+

New Cloud-Based Diabetic Retinopathy Screening Solution - EyeArt - Receives CE Marking

Eyenuk, California-based computer vision and image analysis technologies, has received CE Marking (license to sell products in European Economic Area) for its pioneering EyeArt software.

EyeArt provides a highly-scalable and cost-effective cloud-based diabetic retinopathy screening solution that analyzes thousands of patients' eyes in just a few hours. Using color retinal images taken with standard fundus cameras, the software analyzes the high-resolution images of the retina, and uses this information to automate detection of diabetic retinopathy.


EyeArt is designed to help healthcare professionals identify patients who need immediate attention in a more effective and efficient manner.

Diabetic Retinopathy (DR), a common microvascular complication of diabetes, is the leading cause of blindness in the adult working-age population. Early detection and treatment can reduce the number of people with vision loss caused by DR by up to 90%.

Automation of diabetic retinopathy screening is the only realistic method to screen a large proportion of those with diabetes. This screening will also significantly reduce healthcare costs and improve efficiency for ophthalmologists and other eye care specialists.

Extensive clinical validation studies for EyeArt have shown that the product can achieve better sensitivity than human graders, while cutting the screening workload in half. EyeArt's cloud-based programming interface is expected to be made widely available in Europe and the US within a month.

"Receiving the CE Marking for our flagship screening product, EyeArt, is a significant milestone for Eyenuk. Our exhaustive research and patented image analysis technology behind EyeArt has culminated in a DR screening product that is more sensitive than human graders, while still reducing workloads by more than 50%," said Dr. Kaushal Solanki, CEO of Eyenuk.

Source: Medindia


Recommended Reading

Latest Diabetes News

Why Is Losing a Pancreatic Cell Contributing to Diabetes?
Type 2 diabetes mice injected with beta cells with increased CD63 protein marker production had their blood sugar levels restored to normal.
New Artificial Pancreas can Help Your Child with Diabetes: Here's How
Good news to children with diabetes: New artificial pancreas can help improve blood sugar control in kids.
Bright Lights, Big Risk: Alarming Link Between Light Exposure and Gestational Diabetes!
New study reveals the link between pre-sleep light exposure and gestational diabetes mellitus in pregnant women.
 Ease Diabetic Neuropathy Pain With Spinal Cord Stimulation
Spinal cord stimulation delivers electrical stimulation to the spinal cord to cut off pain signals to the brain and may ease pain associated with diabetic neuropathy.
How Digital Therapeutics Improve Blood Sugar Levels?
Cognitive behavioral therapy delivered via smartphone app was found to lower blood sugar levels in type 2 diabetes people.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

New Cloud-Based Diabetic Retinopathy Screening Solution - EyeArt - Receives CE Marking Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests